Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries
Code effective Jan 01, 2025
HCPCS Section
Transportation Services Including Ambulance, Medical & Surgical Supplies
A9543 is a valid 2026 HCPCS code meaning Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries or (Y90 ibritumomab, rx) for short. HCPCS A9543 has been effective since 01/01/2025 and applies to Therapeutic radiology.
|
HCPCS Level II Code Section A - Transportation Services Including Ambulance, Medical & Surgical Supplies |
|
| HCPCS Code | A9543 |
|---|---|
| Description |
Long description:
Short description: |
| HCPCS Pricing indicator |
51 - Drugs
|
| Multiple pricing indicator |
A - Not applicable as HCPCS priced under one methodology
|
| Coverage code | C - Carrier judgment |
| ASC payment group code | Effective Jan 01, 2025 - This procedure is approved to be performed in an ambulatory surgical center. |
| BETOS2 code | I1E - Standard imaging - nuclear medicine |
| HCPCS Action code | N - No maintenance for this code |
| Type of service | 6 - Therapeutic radiology |
| Effective date | Effective Jan 01, 2025 |
| Date added | Added Jan 01, 2006 |
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026
CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.